CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M
Source: SeekingAlpha
2026-02-27 14:13:41 ET
More on CG Oncology
- CG Oncology, Inc. (CGON) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow
- CG Oncology, Inc. (CGON) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
- CG Oncology: 'Strong Buy' On Earlier Than Expected Completed Recruitment Cretostimogene
- CG Oncology rises after expediting a late-stage trial readout for lead asset
- Seeking Alpha’s Quant Rating on CG Oncology
Read the full article on Seeking Alpha
For further details see:
CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M
CG Oncology, Inc.
NASDAQ: CGON
CGON Trading
1.49% G/L:
$61.085 Last:
495,891 Volume:
$61.44 Open:
CGON Latest News
February 27, 2026 08:30:00 am
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
February 23, 2026 08:00:00 am
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
February 19, 2026 05:15:50 pm
CG Oncology Soars 102% in a Year, but One Investor Just Disclosed a $58.5 Million Sale
CGON Stock Data
$4,282,567,443
74,696,882
0.15%
55
N/A
Biotechnology & Life Sciences
Healthcare
US
Irvine
